Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
March 31, 2026 1.447M
December 31, 2025 -5.103M
September 30, 2025 -4.159M
June 30, 2025 -0.999M
March 31, 2025 -2.993M
December 31, 2024 0.038M
September 30, 2024 -0.179M
June 30, 2024 -3.479M
March 31, 2024 -4.442M
December 31, 2023 -4.921M
September 30, 2023 -8.55M
June 30, 2023 -11.06M
March 31, 2023 -18.20M
December 31, 2022 -30.36M
September 30, 2022 -39.28M
Date Value
June 30, 2022 -37.76M
March 31, 2022 -35.71M
December 31, 2021 -34.35M
September 30, 2021 -35.88M
June 30, 2021 -19.51M
March 31, 2021 -26.56M
December 31, 2020 -26.20M
September 30, 2020 -64.05M
June 30, 2020 -0.2244M
March 31, 2020 -0.5496M
December 31, 2019 -0.2238M
September 30, 2019 -0.6792M
June 30, 2019 -0.1941M
March 31, 2019 -0.0007M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Tenax Therapeutics, Inc. -14.15M
Exicure, Inc. -0.887M
Century Therapeutics, Inc. -20.53M
Absci Corp. -27.56M
Cardio Diagnostics Holdings, Inc. -1.389M